GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Price-to-Owner-Earnings

MYND Life Sciences (XCNQ:MYND) Price-to-Owner-Earnings : (As of May. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Price-to-Owner-Earnings?

As of today (2025-05-30), MYND Life Sciences's share price is C$0.07. MYND Life Sciences does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for MYND Life Sciences's Price-to-Owner-Earnings or its related term are showing as below:


XCNQ:MYND's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.765
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-30), MYND Life Sciences's share price is C$0.07. MYND Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.02. Therefore, MYND Life Sciences's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-30), MYND Life Sciences's share price is C$0.07. MYND Life Sciences's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.04. Therefore, MYND Life Sciences's PE Ratio without NRI for today is At Loss.


MYND Life Sciences Price-to-Owner-Earnings Historical Data

The historical data trend for MYND Life Sciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Price-to-Owner-Earnings Chart

MYND Life Sciences Annual Data
Trend Oct21 Oct22 Oct23
Price-to-Owner-Earnings
- - -

MYND Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MYND Life Sciences's Price-to-Owner-Earnings

For the Biotechnology subindustry, MYND Life Sciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MYND Life Sciences's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MYND Life Sciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where MYND Life Sciences's Price-to-Owner-Earnings falls into.


;
;

MYND Life Sciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

MYND Life Sciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.07/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MYND Life Sciences  (XCNQ:MYND) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


MYND Life Sciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


MYND Life Sciences Business Description

Traded in Other Exchanges
Address
105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.